Literature DB >> 1472966

In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium.

M Y Farhat1, R Vargas, B Dingaan, P W Ramwell.   

Abstract

1. The effect of different concentrations of oestradiol-17 beta (3-300 nM) on [3H]-thymidine uptake was studied in segments from canine pulmonary artery, and cultures of rat pulmonary vascular smooth muscle cells (VSMC). 2. Incubation with oestradiol-17 beta for 24 h, potentiated in a concentration-dependent manner [3H]-thymidine uptake in VSMC cultures. 3. Oestradiol-17 beta potentiated thymidine uptake by pulmonary arterial segments but only when the endothelium had been removed. Autoradiography showed dense incorporation of radioactive thymidine in the vascular smooth muscle cells of the media. 4. The non-steroidal oestrogen, stilboestrol (300 nM), also significantly potentiated [3H]-thymidine uptake, in both VSMC cultures and pulmonary artery segments. Testosterone was ineffective at a similar concentration. 5. Pre-incubation of the pulmonary VSMC with the anti-oestrogen tamoxifen (1 microM) antagonized the potentiating effect of oestradiol-17 beta on [3H]-thymidine incorporation. The effect of tamoxifen was less pronounced in pulmonary arterial segments. 6. These data suggest that oestrogen may promote proliferation of pulmonary VSMC. Endothelial injury or dysfunction may be an important factor in the expression of the oestrogenic effect. 7. We speculate that plasma oestrogen may be a contributing factor to the proliferative lesion observed in certain forms of pulmonary vascular injury in women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472966      PMCID: PMC1907765          DOI: 10.1111/j.1476-5381.1992.tb14506.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  An estrogen-regulated protein in normal and malignant endometrium.

Authors:  W L McGuire; L G Dressler; G W Sledge; I Ramzy; D R Ciocca
Journal:  J Steroid Biochem       Date:  1986-01       Impact factor: 4.292

Review 2.  Biochemical pharmacology of antiestrogen action.

Authors:  V C Jordan
Journal:  Pharmacol Rev       Date:  1984-12       Impact factor: 25.468

Review 3.  Primary pulmonary hypertension. A review.

Authors:  R Savajiyani; A Benchimol; K B Desser
Journal:  Ariz Med       Date:  1981-12

4.  Estrogen regulation of specific messinger RNA's in human breast cancer cells.

Authors:  D J Adams; D P Edwards; W L McGuire
Journal:  Biochem Biophys Res Commun       Date:  1980-12-31       Impact factor: 3.575

5.  Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors.

Authors:  A L Lin; H C McGill; S A Shain
Journal:  Circ Res       Date:  1982-05       Impact factor: 17.367

6.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

8.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

9.  Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys.

Authors:  T B Clarkson; C A Shively; T M Morgan; D R Koritnik; M R Adams; J R Kaplan
Journal:  Obstet Gynecol       Date:  1990-02       Impact factor: 7.661

10.  Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle.

Authors:  D R Harder; P B Coulson
Journal:  J Cell Physiol       Date:  1979-08       Impact factor: 6.384

View more
  10 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.

Authors:  F D Kolodgie; A Jacob; P S Wilson; G C Carlson; A Farb; A Verma; R Virmani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice.

Authors:  R H Karas; J B Hodgin; M Kwoun; J H Krege; M Aronovitz; W Mackey; J A Gustafsson; K S Korach; O Smithies; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved.

Authors:  B Paquette; P K Fortier; J Héroux; P A Thibodeau; R Wagner; J Liu; A Cantin
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 5.  Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.

Authors:  Stevan P Tofovic
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

6.  Growth and phenotypic characterization of porcine coronary artery smooth muscle cells.

Authors:  M C Lavigne; P W Ramwell; R Clarke
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-03       Impact factor: 2.416

7.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

8.  2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats.

Authors:  Stevan P Tofovic; Xinchen Zhang; Edwin K Jackson; Hong Zhu; Gordana Petrusevska
Journal:  Vascul Pharmacol       Date:  2009-06-21       Impact factor: 5.773

9.  Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats.

Authors:  M Y Farhat; M F Chen; T Bhatti; A Iqbal; S Cathapermal; P W Ramwell
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) Signaling.

Authors:  Hiroaki Sunaga; Hiroki Matsui; Saki Anjo; Mas Risky A A Syamsunarno; Norimichi Koitabashi; Tatsuya Iso; Takashi Matsuzaka; Hitoshi Shimano; Tomoyuki Yokoyama; Masahiko Kurabayashi
Journal:  J Am Heart Assoc       Date:  2016-11-23       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.